Streetbeat News

Legal

NTDOY

Pocketpair released a major update for Palworld, introducing the first raid boss, Bellanoir, and various new features and items. The update includes summoning Raid Boss Pals, Training Manuals, Recovery Meds, and the Homeward Thundercloud. It also addresses UI improvements, balancing, bug fixes, and anti-cheating measures. Despite controversy over being a Pokémon clone, leading to actions by Nintendo ADR (OTC:NTDOY), Palworld continues to grow, with the player base looking forward to more updates.

Portfolio Pulse from Franca Quarneti

April 04, 2024 | 6:48 pm

DJT

SPY

A recent court ruling has denied former President Donald Trump's attempt to dismiss a case concerning the handling of documents, based on his claim that they were 'personal' records. This development marks a significant moment in the ongoing legal challenges faced by Trump.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 6:46 pm

ABUS

MRNA

A Delaware District Court ruled in favor of Arbutus Biopharma Corporation (ABUS) and Genevant Sciences in their patent infringement lawsuit against Moderna Inc (MRNA) regarding Moderna's COVID-19 vaccine. The court's decision strengthens the plaintiffs' case by supporting their interpretation of the contested patent terms related to a lipid nanoparticle platform crucial for the vaccine's delivery. Arbutus and Genevant are seeking compensation for Moderna's use of this technology. JMP Securities maintains a Market Outperform rating on ABUS with a price target of $4. ABUS shares rose 3.25% to $3.02, while MRNA shares increased by 3.89% to $105.2.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 6:32 pm

MRNA

Moderna's stock is experiencing a rebound after a decline on Wednesday due to Arbutus receiving permission to pursue a patent claim against Moderna. This legal development had initially negatively impacted Moderna's stock price.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:57 pm

GIL

HBI

The future of Gildan Activewear Inc. is under intense scrutiny as a series of events including the firing of its CEO, pressure from a rebel investor, and discussions about mergers and acquisitions (M&A) stir a significant battle for control and direction. These developments have put the spotlight on the company's strategic decisions and governance, raising questions about its next moves in the face of these challenges.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:36 pm

BNTX

CVAC

GSK

CureVac N.V. (CVAC) and GSK Plc (GSK) released interim data from their seasonal influenza vaccine study, showing promising results across all age groups and dose levels. The vaccine, designed for broad antigen coverage, demonstrated strong antibody titers and an acceptable safety profile. The study is part of a collaboration between CureVac and GSK, focusing on a multivalent vaccine candidate using CureVac's second-generation mRNA technology. Additionally, CureVac is involved in ongoing patent litigation with BioNTech SE (BNTX) over intellectual property rights.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 4:18 pm

DJT

A judge has dismissed Donald Trump's challenge to the Georgia 2020 election case, which was based on free speech grounds. The decision was reported by Reuters, citing the court's ruling.

Portfolio Pulse from Charles Gross

April 04, 2024 | 4:18 pm

DIS

Disney CEO Bob Iger discussed the company's victory in its proxy battle against activist investors, emphasizing the distraction it caused and his relief over the outcome. Iger criticized Nelson Peltz for not bringing new ideas and potentially being a destructive presence on the board. The engagement during the proxy battle highlighted shared priorities among Disney's board, executives, and shareholders. Iger's focus will now return to core business priorities, including film quality, streaming profitability, ESPN's future, and the growth of Disney parks and resorts. Disney shares were up 0.73% at $119.85 following the news.

Portfolio Pulse from Erica Kollmann

April 04, 2024 | 4:07 pm

SNDL

SNDL, Inc. (NASDAQ:SNDL) shares have surged over 75% in the past month but are experiencing a pullback after a 22.6% gain on Wednesday. The cannabis sector's rally is attributed to legalization in Germany, potential rescheduling in the U.S., and a Florida Supreme Court ruling allowing a recreational marijuana legalization initiative on the November ballot. SNDL is trending on Yahoo Finance and WallStreetBets. Technical analysis suggests SNDL's current price is above its 200-day moving average, indicating bullish sentiment.

Portfolio Pulse from Erica Kollmann

April 04, 2024 | 3:49 pm

BORR

Borr Drilling Limited (NYSE:BORR) shares fell over 5% due to a notice of temporary suspension of operations for its rig 'Arabia I' in Saudi Arabia for up to 12 months, starting in Q2. The company plans to seek alternative engagement for the rig during this period. Despite this setback, Borr Drilling has secured several new contracts in 2023, adding $728 million, with an implied rate of approximately $161,000 per day. Firm contracts and priced options already cover 87% of available capacity in 2024. Over the past year, BORR stock has lost over 23%.

Portfolio Pulse from Nabaparna Bhattacharya

April 04, 2024 | 3:40 pm